Y
Yoav Ben-Shlomo
Researcher at University of Bristol
Publications - 678
Citations - 67137
Yoav Ben-Shlomo is an academic researcher from University of Bristol. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 110, co-authored 628 publications receiving 59538 citations. Previous affiliations of Yoav Ben-Shlomo include University of Vermont & Imperial College London.
Papers
More filters
Journal ArticleDOI
Modeling the need for hip and knee replacement surgery. Part 2. Incorporating census data to provide small-area predictions for need with uncertainty bounds.
TL;DR: For the first time, small-area estimates of need for hip/knee replacement surgery have been produced together with estimates of uncertainty to inform local health planning and could be reproduced in other countries and for other disease indicators.
Journal ArticleDOI
Admission patterns and survival from status epilepticus in critical care in the UK: an analysis of the Intensive Care National Audit and Research Centre Case Mix Programme database.
TL;DR: Survival for patients with status epilepticus was examined to establish whether the risk of mortality has changed over time and whether admission to different unit types affects mortality risk over and above other risk factors.
Journal ArticleDOI
Identifying low density lipoprotein cholesterol associated variants in the Annexin A2 (ANXA2) gene
Roaa Hani Fairoozy,Jackie A. Cooper,Jon White,Claudia Giambartolomei,Lasse Folkersen,SG Wannamethee,Barbara J. Jefferis,Peter H. Whincup,Yoav Ben-Shlomo,Meena Kumari,Mika Kivimäki,Andrew Wong,Rebecca Hardy,Diana Kuh,Tom R. Gaunt,Juan P. Casas,Stela McLachlan,Jackie F. Price,Aroon D. Hingorani,Anders Franco-Cereceda,Thomas Grewal,Anastasia Z. Kalea,Steve E. Humphries +22 more
TL;DR: This study supports, for the first time in humans, previous observations in mouse models that changes in the levels of AnxA2 directly influence plasma LDL-C levels, and thus implicate this protein as a potential therapeutic target for LDL- C lowering.
Journal ArticleDOI
The minimum clinically important difference (MCID) for a falls intervention in Parkinson's: A delphi study.
TL;DR: It is established that an expert panel of PD specialists consider that an intervention that demonstrated a 25% (IQR 20-25%) relative reduction in falls rate would be clinically meaningful and can be used to help determine the sample size for any future clinical trial.